Case Report and Literature Review of an Atypical Polymyalgia Rheumatica and Its Management

References

• Muratore F, Pazzola G, Pipitone N, Salvarani C. Recent advances in the diagnosis and treatment of polymyalgia rheumatica. Expert Rev Clin Immunol. 2016;12(10):1037–1045. doi:10.1080/1744666X.2016.1178572
   PubMed Web of Science ®Google Scholar
• Verhoeven F, Prati C, Guillot X, Boulahdour H, Wendling D. Sterno-clavicular involvement in polymyalgia rheumatica. Joint Bone Spine. 2016;83(3):363–364. doi:10.1016/j.jbspin.2015.04.015
   PubMed Web of Science ®Google Scholar
• Talke M, Schmidt WA. Polymyalgia rheumatica in der täglichen Praxis [Polymyalgia rheumatica in daily routine practice]. Z Rheumatol. 2014;73(5):408–414. German. doi:10.1007/s00393-013-1344-1
   PubMed Web of Science ®Google Scholar
• Mager DR. Polymyalgia rheumatica: common disease, elusive diagnosis. Home Healthcare Now. 2015;33(3):132–6; quiz 7–8. doi:10.1097/NHH.0000000000000199
   Google Scholar
• Um YJ, Kim HA, Jung JH, Cho H, Kang JK. A case of amyloidosis presenting as chronic cholecystitis, misdiagnosed as polymyalgia rheumatica. Korean J Gastroenterol. 2016;68(1):49–53. doi:10.4166/kjg.2016.68.1.49
   PubMedGoogle Scholar
• Klausen HH, Petersen J, Bandholm T, et al. Association between routine laboratory tests and long-term mortality among acutely admitted older medical patients: a cohort study. BMC Geriatr. 2017;17(1):62. doi:10.1186/s12877-017-0434-3
   PubMedGoogle Scholar
• Lohman M, Dumenci L, Mezuk B. Depression and Frailty in Late Life: evidence for a Common Vulnerability. J Gerontol B Psychol Sci Soc Sci. 2016;71(4):630–640. doi:10.1093/geronb/gbu180
   PubMed Web of Science ®Google Scholar
• Vaughan L, Corbin AL, Goveas JS. Depression and frailty in later life: a systematic review. Clin Interv Aging. 2015;10:1947–1958. doi:10.2147/CIA.S69632
   PubMed Web of Science ®Google Scholar
• Alisky JM. Do not overlook polymyalgia rheumatica as a cause for immobility in poorly communicating dementia patients. South Med J. 2008;101(12):1277–1278. doi:10.1097/SMJ.0b013e3181819f48
   PubMed Web of Science ®Google Scholar
• Duarte C, Ferreira RJ, Mackie SL, Kirwan JR, Pereira da Silva JA; Group OPRSI. Outcome measures in polymyalgia rheumatica. A systematic review. J Rheumatol. 2015;42(12):2503–2511. doi:10.3899/jrheum.150515
   PubMed Web of Science ®Google Scholar
• Ozen G, Inanc N, Unal AU, et al. Assessment of the new 2012 EULAR/ACR clinical classification criteria for polymyalgia rheumatica: a prospective multicenter study. J Rheumatol. 2016;43(5):893–900. doi:10.3899/jrheum.151103
   PubMed Web of Science ®Google Scholar
• Ezeonyeji AN, Borg FA, Dasgupta B. Delays in recognition and management of giant cell arteritis: results from a retrospective audit. Clin Rheumatol. 2011;30(2):259–262. doi:10.1007/s10067-010-1616-y
   PubMed Web of Science ®Google Scholar
• Kermani TA, Warrington KJ. Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica. Ther Adv Musculoskelet Dis. 2014;6(1):8–19. doi:10.1177/1759720X13512450
   PubMedGoogle Scholar
• Manzo C, Natale M. Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set. Open Access Rheumatol. 2016;8:93–95. doi:10.2147/OARRR.S116036
   PubMedGoogle Scholar
• Muller S, Hider SL, Belcher J, Helliwell T, Mallen CD. Is cancer associated with polymyalgia rheumatica? A cohort study in the general practice research database. Ann Rheum Dis. 2014;73(10):1769–1773. doi:10.1136/annrheumdis-2013-203465
   PubMed Web of Science ®Google Scholar
• Yates M, Watts RA, Swords F, MacGregor AJ. Glucocorticoid withdrawal in polymyalgia rheumatica: the theory versus the practice. Clin Exp Rheumatol. 2017;35(1):1–2.
   PubMed Web of Science ®Google Scholar
• Plaza M, Nowakowska-Plaza A, Pracon G, Sudol-Szopinska I. Role of ultrasonography in the diagnosis of rheumatic diseases in light of ACR/EULAR guidelines. J Ultrason. 2016;16(64):55–64. doi:10.15557/JoU.2016.0006
   PubMedGoogle Scholar
• Dasgupta B, Cimmino MA, Kremers HM, et al. 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum. 2012;64(4):943–954. doi:10.1002/art.34356
   PubMed Web of Science ®Google Scholar
• Kermani TA, Warrington KJ. Polymyalgia rheumatica. Lancet. 2013;381(9860):63–72. doi:10.1016/S0140-6736(12)60680-1
   PubMed Web of Science ®Google Scholar
• Salvarani C, Pipitone N, Versari A, Hunder GG. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol. 2012;8(9):509–521. doi:10.1038/nrrheum.2012.97
   PubMed Web of Science ®Google Scholar
• Dejaco C, Singh YP, Perel P, et al. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2015;74(10):1799–1807. doi:10.1136/annrheumdis-2015-207492
   PubMed Web of Science ®Google Scholar
• Mackie SL, McGonagle DG. Response to: ‘A relationship between extracapsular involvement and response to steroid treatment in polymyalgia rheumatica: too soon to conclude?’ by Yang et al. Ann Rheum Dis. 2016;75(4):e17. doi:10.1136/annrheumdis-2015-208956
   PubMed Web of Science ®Google Scholar
• Diamantopoulos AP, Hetland H, Myklebust G. Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series. Biomed Res Int. 2013;2013:120638. doi:10.1155/2013/120638
   PubMed Web of Science ®Google Scholar
• Ferraccioli G, Salaffi F, De Vita S, Casatta L, Bartoli E. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheumatol. 1996;23(4):624–628.
   PubMed Web of Science ®Google Scholar
• Watson P, Gaston H. Response to ‘Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial’. Arthritis Res Therapy. 2011;13(2):403. doi:10.1186/ar3269
   PubMed Web of Science ®Google Scholar
• Schmidt WA. Polymyalgia rheumatica [Polymyalgia rheumatic--what’s new?]. Dtsch Med Wochenschr. 2016;141(7):490–492. German.. doi:10.1055/s-0042-100099
   PubMed Web of Science ®Google Scholar
• Li WL, Lo Y, Leung MH, Wong WS, Mok MY. The clinical course of polymyalgia rheumatica in Chinese. Clin Rheumatol. 2010;29(2):199–203. doi:10.1007/s10067-009-1315-8
   PubMed Web of Science ®Google Scholar
• Bordin G, Atzeni F, Bettazzi L, Beyene NB, Carrabba M, Sarzi-Puttini P. Unilateral polymyalgia rheumatica with controlateral sympathetic dystrophy syndrome. A case of asymmetrical involvement due to pre-existing peripheral palsy. Rheumatology (Oxford). 2006;45(12):1578–1580. doi:10.1093/rheumatology/kel334
   PubMed Web of Science ®Google Scholar
• van Dalen-Kok AH, Pieper MJ, de Waal MW, Lukas A, Husebo BS, Achterberg WP. Association between pain, neuropsychiatric symptoms, and physical function in dementia: a systematic review and meta-analysis. BMC Geriatr. 2015;15:49. doi:10.1186/s12877-015-0048-6
   PubMed Web of Science ®Google Scholar
• Kreiner FF, Galbo H. Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-alpha blocking etanercept treatment. Arthritis Res Therapy. 2012;14(4):R186. doi:10.1186/ar4017
   PubMed Web of Science ®Google Scholar
• Visvanathan S, Rahman MU, Hoffman GS, et al. Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal study. Rheumatology (Oxford). 2011;50(11):2061–2070. doi:10.1093/rheumatology/ker163
   PubMed Web of Science ®Google Scholar
• Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxford). 2002;41(7):809–814. doi:10.1093/rheumatology/41.7.809
   PubMed Web of Science ®Google Scholar
• Codreanu C, Enache L. Is ultrasound changing the way we understand rheumatology? Including ultrasound examination in the classification criteria of polymyalgia rheumatica and gout. Med Ultrason. 2015;17(1):97–103. doi:10.11152/mu.2013.2066.171.ccle
   PubMed Web of Science ®Google Scholar
• Emamifar A, Hess S, Gildberg-Mortensen R, Jensen Hansen IM. Association of remitting seronegative symmetrical synovitis with pitting edema, polymyalgia rheumatica, and adenocarcinoma of the prostate. Am J Case Rep. 2016;17:60–64. doi:10.12659/ajcr.895717
   PubMedGoogle Scholar
• Nesher G, Breuer GS. Giant cell arteritis and polymyalgia rheumatica: 2016 update. Rambam Maimonides Med J. 2016;7(4):e0035. doi:10.5041/RMMJ.10262
   PubMedGoogle Scholar
• Cherif Y, Zantour B, Alaya W, Berriche O, Younes S, Sfar MH. Primary hyperparathyroidism and hyperthyroidism in a patient with myotonic dystrophy: a case report and review of the literature. Case Rep Endocrinol. 2015;2015:735868. doi:10.1155/2015/735868
   PubMedGoogle Scholar
• Dalkilic E, Tufan AN, Hafizoglu E, et al. The process from symptom onset to rheumatology clinic in polymyalgia rheumatica. Rheumatol Int. 2014;34(11):1589–1592. doi:10.1007/s00296-014-3034-y
   PubMed Web of Science ®Google Scholar
• Das P, Samanta A, Dasgupta B. Balancing on the edge: implications of a UK national audit of the use of BSR-BHPR guidelines for the diagnosis and management of polymyalgia rheumatica. RMD Open. 2015;1(1):e000095. doi:10.1136/rmdopen-2015-000095
   PubMedGoogle Scholar
• de Jong HJ, Meyboom RH, Helle MJ, Klungel OH, Niskanen L, Cohen Tervaert JW. Giant cell arteritis and polymyalgia rheumatica after reexposure to a statin: a case report. Ann Intern Med. 2014;161(8):614–615. doi:10.7326/L14-5020-6
   PubMed Web of Science ®Google Scholar
• Dejaco C, Matteson EL, Buttgereit F. Diagnostik und Therapie der Polymyalgia rheumatica [Diagnostics and treatment of polymyalgia rheumatica]. Z Rheumatol. 2016;75(7):687–700. German. doi:10.1007/s00393-016-0105-3
   PubMed Web of Science ®Google Scholar
• Dejaco C, Singh YP, Perel P, et al. Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica. Ann Rheum Dis. 2015;74(10):1808–1817. doi:10.1136/annrheumdis-2015-207578
   PubMed Web of Science ®Google Scholar
• Wakura D, Kotani T, Takeuchi T, et al. Differentiation between polymyalgia rheumatica (PMR) and elderly-onset rheumatoid arthritis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography: is enthesitis a new pathological lesion in PMR? PLoS One. 2016;11(7):e0158509. doi:10.1371/journal.pone.0158509
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev. 2008;21(3):473–494. doi:10.1128/CMR.00001-08
   PubMed Web of Science ®Google Scholar
• Wysoki MG, Angeid-Backman E, Izes BA. Iliopsoas myositis mimicking appendicitis: MRI diagnosis. Skeletal Radiol. 1997;26(5):316–318. doi:10.1007/s002560050244
   PubMed Web of Science ®Google Scholar
• Beese MS, Winkler G, Maas R, Bucheler E. MRT der Muskulatur bei Myalgien. Indikationen und Bildbefunde [MRI of musculature in myalgia--indications and image findings]. Aktuelle Radiol. 1996;6(3):119–129. German.
   PubMedGoogle Scholar
• Ochi J, Nozaki T, Okada M, et al. MRI findings of the shoulder and Hip joint in patients with polymyalgia rheumatica. Mod Rheumatol. 2015;25(5):761–767. doi:10.3109/14397595.2015.1008725
   PubMed Web of Science ®Google Scholar
• Mackie SL, Koduri G, Hill CL, et al. Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review. RMD Open. 2015;1(1):e000100. doi:10.1136/rmdopen-2015-000100
   PubMedGoogle Scholar
• Halls S, Sinnathurai P, Hewlett S, et al. Stiffness is the cardinal symptom of inflammatory musculoskeletal diseases, yet still variably measured: report from the OMERACT 2016 Stiffness Special Interest Group. J Rheumatol. 2016. doi:10.3899/jrheum.161073
   Web of Science ®Google Scholar
• Mackie SL, Pease CT, Fukuba E, et al. Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids. Ann Rheum Dis. 2015;74(12):2188–2192. doi:10.1136/annrheumdis-2015-207395
   PubMed Web of Science ®Google Scholar
• Jou IM, Chiu NT, Lai KA, Chuang YC. Synchronous pyomyositis and septic Hip arthritis. Clin Rheumatol. 2000;19(5):385–388. doi:10.1007/pl00011176
   PubMed Web of Science ®Google Scholar
• Kinoshita S, Aoki T, Takahashi H, et al. Thin-section chest CT findings in polymyalgia rheumatica: a comparison between with and without rheumatoid arthritis. Clin Imaging. 2016;40(3):382–385. doi:10.1016/j.clinimag.2015.11.013
   PubMed Web of Science ®Google Scholar
• Palard-Novello X, Querellou S, Gouillou M, et al. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment. Eur J Nucl Med Mol Imaging. 2016;43(4):773–779. doi:10.1007/s00259-015-3287-z
   PubMed Web of Science ®Google Scholar
• Te Riele MG, Schreuder TH, van Alfen N, et al. The yield of diagnostic work-up of patients presenting with myalgia, exercise intolerance, or fatigue: a prospective observational study. Neuromuscul Disord. 2017;27(3):243–250. doi:10.1016/j.nmd.2016.12.002
   PubMed Web of Science ®Google Scholar
• Mege D, Cammilleri S, Mundler O, et al. Circulating microparticles bearing Fibrin associated with whole-body 18FDG-PET: diagnostic tools to detect paraneoplastic polymyalgia rheumatica. Rheumatol Int. 2016;36(8):1099–1103. doi:10.1007/s00296-016-3510-7
   PubMed Web of Science ®Google Scholar
• Miceli MC, Zoli A, Peluso G, Bosello S, Gremese E, Ferraccioli G. Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: a 12-month followup study. J Rheumatol. 2017;44(2):241–247. doi:10.3899/jrheum.160090
   PubMed Web of Science ®Google Scholar
• Yamashita H, Kubota K, Mimori A. Clinical value of whole-body PET/CT in patients with active rheumatic diseases. Arthritis Res Therapy. 2014;16(5):423. doi:10.1186/s13075-014-0423-2
   PubMed Web of Science ®Google Scholar
• Tateyama M, Fujihara K, Misu T, Arai A, Kaneta T, Aoki M. Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation. BMJ Open. 2015;5(1):e006763. doi:10.1136/bmjopen-2014-006763
   PubMed Web of Science ®Google Scholar
• Fitzcharles MA, Esdaile JM. Atypical presentations of polymyalgia rheumatica. Arthritis Rheum. 1990;33(3):403–406. doi:10.1002/art.1780330314
   PubMedGoogle Scholar
• Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979;38(5):434–439. doi:10.1136/ard.38.5.434
   PubMed Web of Science ®Google Scholar
• Hu Z, Yang Q, Zeng S, et al. Giant cell arteritis in China: a prospective investigation. Angiology. 2002;53(4):457–463. doi:10.1177/000331970205300413
   PubMed Web of Science ®Google Scholar
• Muller S, Hider SL, Helliwell T, et al. Characterising those with incident polymyalgia rheumatica in primary care: results from the PMR Cohort Study. Arthritis Res Therapy. 2016;18:200. doi:10.1186/s13075-016-1097-8
   PubMed Web of Science ®Google Scholar
• Cantini F, Niccoli L, Storri L, et al. Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum. 2004;33(5):294–301. doi:10.1016/j.semarthrit.2003.09.008
   PubMed Web of Science ®Google Scholar
• Chen C-H, Kung S-Y, Tsai -Y-Y, Liao H-T, Chou C-T, Huang D-F. Temporal arteritis. J Chin Med Assoc. 2005;68(7):333–335. doi:10.1016/S1726-4901(09)70170-4
   PubMedGoogle Scholar
• Hyatt A, Lipson-Smith R, Schofield P, et al. Communication challenges experienced by migrants with cancer: a comparison of migrant and English-speaking Australian-born cancer patients. Health Expect. 2017;20(5):886–895. doi:10.1111/hex.12529
   PubMed Web of Science ®Google Scholar
• Benucci M, Olivito B, Manfredi M, et al. Polymyalgia rheumatica: inflammation suppression with low dose of methylprednisolone or modified-release prednisone. Eur Rev Med Pharmacol Sci. 2015;19(5):745–751.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhou H, Tang H, Lee AM, Bai HX. A relationship between extracapsular involvement and response to steroid treatment in polymyalgia rheumatica: too soon to conclude? Ann Rheum Dis. 2016;75(4):e16. doi:10.1136/annrheumdis-2015-208956
   PubMed Web of Science ®Google Scholar
• Twohig H, Mitchell C, Mallen C, Adebajo A, Mathers N. ”I suddenly felt I’d aged”: a qualitative study of patient experiences of polymyalgia rheumatica (PMR). Patient Educ Couns. 2015;98(5):645–650. doi:10.1016/j.pec.2014.12.013
   PubMed Web of Science ®Google Scholar
• Lim T, Woo S, Mun YG, Yim E, Koh JH, Park KS. Polymyalgia rheumatica following paraspinal muscle inflammation and sacroiliitis. Korean J Intern Med. 2015;30(3):415–417. doi:10.3904/kjim.2015.30.3.415
   PubMed Web of Science ®Google Scholar
• Mansalis K. Myalgias and myopathies: polymyalgia rheumatica and giant cell arteritis. FP Essent. 2016;440:16–22.
   PubMedGoogle Scholar
• Manzo C. Widespread headache as the first clinical manifestation of giant cell arteritis in patients affected by polymyalgia rheumatica. Reumatologia. 2016;54(5):236–238. doi:10.5114/reum.2016.63663
   PubMedGoogle Scholar
• Nwadibia U, Larson E, Fanciullo J. Polymyalgia rheumatica and giant cell arteritis: a review article. S D Med. 2016;69(3):121–123.
   PubMedGoogle Scholar
• Luo YB, Mastaglia FL. Dermatomyositis, polymyositis and immune-mediated necrotising myopathies. Biochim Biophys Acta. 2015;1852(4):622–632. doi:10.1016/j.bbadis.2014.05.034
   PubMed Web of Science ®Google Scholar
• Ji J, Liu X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden. Rheumatology (Oxford). 2010;49(6):1158–1163. doi:10.1093/rheumatology/keq040
   PubMed Web of Science ®Google Scholar
• Barraclough K, Mallen CD, Helliwell T, Hider SL, Dasgupta B. Diagnosis and management of giant cell arteritis. Br J Gen Pract. 2012;62(599):329–330. doi:10.3399/bjgp12X649313
   PubMed Web of Science ®Google Scholar
• de Jong HJ, Saldi SR, Klungel OH, et al. Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approach. PLoS One. 2012;7(7):e41289. doi:10.1371/journal.pone.0041289
   PubMed Web of Science ®Google Scholar
• Schmidt WA. Myalgien bei Polymyalgia rheumatica, Arteriitis temporalis und anderen Vaskulitiden [Myalgia in polymyalgia rheumatica, temporal arteritis and other vasculitides]. Z Rheumatol. 2009;68(6):446–450. German. doi:10.1007/s00393-009-0453-3
   PubMed Web of Science ®Google Scholar
• Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016;315(22):2442–2458. doi:10.1001/jama.2016.5444
   PubMed Web of Science ®Google Scholar
• Toussirot E, Martin A, Soubrier M, Redeker S, Regent A. Rapid and sustained response to tocilizumab in patients with polymyalgia rheumatica resistant or intolerant to glucocorticoids: a multicenter open-label study. J Rheumatol. 2016;43(1):249–250. doi:10.3899/jrheum.150599
   PubMed Web of Science ®Google Scholar
• Fry CS, Nayeem SZ, Dillon EL, et al. Glucocorticoids increase skeletal muscle NF-kappaB inducing kinase (NIK): links to muscle atrophy. Physiol Rep. 2016;4(21). doi:10.14814/phy2.13014
   Google Scholar
• Ennis GE, An Y, Resnick SM, Ferrucci L, O’Brien RJ, Moffat SD. Long-term cortisol measures predict Alzheimer disease risk. Neurology. 2017;88(4):371–378. doi:10.1212/WNL.0000000000003537
   PubMed Web of Science ®Google Scholar
• Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001;134(2):106–114. doi:10.7326/0003-4819-134-2-200101160-00010
   PubMed Web of Science ®Google Scholar
• Toussirot E, Regent A, Devauchelle-Pensec V, Saraux A, Puechal X. Interleukin-6: a promising target for the treatment of polymyalgia rheumatica or giant cell arteritis? RMD Open. 2016;2(2):e000305. doi:10.1136/rmdopen-2016-000305
   PubMedGoogle Scholar
• Kreiner F, Galbo H. Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial. Arthritis Res Ther. 2010;12(5):R176. doi:10.1186/ar3140
   PubMed Web of Science ®Google Scholar
• Manzo C, Hysa E, Castagna A, Isetta M. The role of tumor necrosis factor alpha antagonists (Anti TNF-α) in personalized treatment of patients with isolated polymyalgia rheumatica (PMR): past and possible future scenarios. J Pers Med. 2022;12(3):329. doi:10.3390/jpm12030329
   PubMed Web of Science ®Google Scholar
• Hysa E, Bond M, Ehlers L, et al. Andreas Kerschbaumer, Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review. Rheumatology. 2023;kead471. doi:10.1093/rheumatology/kead471
   PubMed Web of Science ®Google Scholar
• Wu J, Yang F, Ma X, Lin J, Chen W. Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: differences in pathogenesis. Front Med. 2023;9:1083879. doi:10.3389/fmed.2022.1083879
   Web of Science ®Google Scholar
• Ohta R, Sano C. Differentiating between seronegative elderly-onset rheumatoid arthritis and polymyalgia rheumatica: a qualitative synthesis of narrative reviews. Int J Environ Res Public Health. 2023;20:1789. doi:10.3390/ijerph20031789
   PubMedGoogle Scholar
• Lange U, Piegsa M, Teichmann J, et al. Ultrasonography of the glenohumeral joints – a helpful instrument in differentiation in elderly onset rheumatoid arthritis and polymyalgia rheumatica. Rheumatol Int. 2000;19:185–189. doi:10.1007/s002960000051
   PubMed Web of Science ®Google Scholar
• Coskun Benlidayi I. Why is polymyalgia rheumatica a disease of older adults? Explanations through etiology and pathogenesis: a narrative review. Clin Rheumatol. 2023. doi:10.1007/s10067-023-06708-3
   PubMed Web of Science ®Google Scholar
• Carvajal Alegria G, Boukhlal S, Cornec D, Devauchelle-Pensec V. The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle. Autoimmun Rev. 2020;19(11):102670. doi:10.1016/j.autrev.2020.102670
   PubMed Web of Science ®Google Scholar